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Abstract  
Objectives:  
Orbital infections are regularly encountered and are managed by various healthcare 
disciplines. Sepsis of the orbit and adjacent tissues can be associated with considerable acute 
complication and long term sequelae. Therefore, prompt recognition and management of this 
condition are crucial. This article presents the outcomes of a 7-year complete cycle audit 
project and describes the development of the new local guideline on the management of 
orbital infections in our tertiary centre. 
Methods:  
1. A retrospective 5-year audit cycle on patients with orbital infections 
2. A review of available evidence on the management of orbital infections  
3. A new local multidisciplinary guideline on the management of orbital infections 
4. A retrospective 2-year second audit cycle to assess the clinical outcomes 
Results:  
Various disciplines intersect in the management of orbital infections. Standardising the 
management of this condition proved to be achievable through the developed guideline. 
However, room for improvement in practice exists in areas such as the promptness in 
referring patients to specialist care, the multidisciplinary assessment of patients on admission, 
and the improvement of scanning requests of patients.  
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Introduction 
Infections of the orbit and surrounding tissues vary in their severity and in the definitions that 
are assigned to them in the literature [1-3]. Although the reported incidence differs in the 
literature, there is agreement that orbital infections are seen regularly in tertiary centres, and 
that they have a higher prevalence and a greater frequency of complications in children [1, 4-
7].    
Orbital infections can be categorised according to the extent of sepsis (pre-septal / periorbital 
vs. Post-septal / orbital) [3, 8, 9], or according to the severity (cellulitis / subperiosteal 
abscess / intra-orbital abscess). The most universally used classification, that combines the 
extent and severity of the infection, is that of Chandler et al (Table 1) [1, 10, 11, 12].  
The source that instigates the septic chain is predominantly the para-nasal sinuses [1, 13]; 
however, the infection can spread from any of the neighbouring structures [13, 
14].Historically, Haemophilus Influenzae, prior to its inoculation, had been recognised as the 
commonest microbial culprit. Thereafter, the most commonly yielded microbes from orbital 
sepsis specimens have become various Streptococcus and Staphylococcus species [11, 15, 16, 
17].  
Poorly managed orbital infections can cause severe and life threatening sequelae such as 
blindness and intracranial complications [1, 12, 14, 18]. The severity of the disease and the 
incidence of complications have been limited greatly due to the developments in diagnostic 
and remedial abilities; however, evidence of morbidity and mortality still exists [20]. For 
instance, there is an up to 10% incidence of blindness that is reported in cases where the 
treatment of orbital sepsis was delayed [18, 19]. Hence, there is a call for a shift towards a 
clinical practice that focuses on early recognition and intervention [11, 18].  
The clinical assessment of orbital infections can be challenging especially in younger people. 
Moreover, the clinical examination can be insufficient solely as a tool to identify the severity 
of the disease [18]. Computed tomography (CT) is considered to be the gold standard 
complimentary test that identifies the formation of abscesses, their extension, the presence of 
intracranial complications, and the presence of associated sinus disease[3, 9, 11, 18]. While 
considering the risks of radiological exposure, clinicians should consider CT imaging with 
contrast (of the brain, orbits and sinuses) when abscesses or further complications are 
suspected [11, 18, 25].  
Due to the various initial sources of infection, the diversity of patients’ demographics, and to 
the wide spectrum of complications, many disciplines overlap during the management of 
orbital infections. The literature provides little evidence on who should manage and how they 
should manage the patient with orbital sepsis [1, 5, 13, 21]. Thus, different protocols are 
available in the literature regarding the management of orbital infections [22]; for instance, 
one of the known guidelines in the UK is that by Howe and Jones (2004) [3, 23, 24]. More 
recently, ENT UK published revised guidelines on the management of orbital cellulitis for 
adults and paediatric patients [25].  
In this article we present a 7-year complete cycle audit project that aimed to systematically 
evaluate and standardise our clinical practice regarding the management of orbital infections. 
In this project, we examined the practice in our tertiary centre regarding orbital infections 
retrospectively for five years [26]. The data was thereafter compared to the most recently 
available evidence through a comprehensive literature review. The outcomes of the 
comparison were employed thereafter to construct a multidisciplinary local guideline on the 
management of orbital infections. Following the implementation of the guideline, a second 
two-year cycle of retrospective data was carried out in order to evaluate the change that had 
been achieved. The article provides analysis of the final outcomes of the project and suggests 
further steps that can be taken in order to allow future improvements in patients’ care.  
Methodology: 
1- First cycle 
We performed a retrospective data collection regarding patients who had an 
admission and a diagnosis of an orbital infection in our tertiary centre over 5 years 
(2008-2012). Patients were recognised through a systematic coding approach (we 
searched the codes of: orbital infection, periorbital infection, orbital cellulitis, 
periorbital cellulitis, orbital abscess, periorbital abscess, orbital sepsis, periorbital 
sepsis and subperiosteal abscess). The coded list was reviewed and data that was 
related to coding errors was disregarded. The remaining patients’ notes were then 
obtained and reviewed so only patients who had orbital infections were included in 
the analysis. All patients’ data was assigned to an audit performa to assess all relevant 
details of our practice. The data was collected from after the year 2007 as the first 
international guideline (the European Position Paper / EPOS) for managing sinusitis 
and its complications by EPOS was first published in 2005/2006. 
2- Literature review[24] 
A review of the literature was performed through a systematic search of available 
evidence on the databases of Embase, Medline and Cochrane.  
The used terms were ‘orbital’, ‘periorbital’, ‘peri-orbital’, ‘cellulitis’, ‘infection’, 
‘sepsis’, ‘abscess’ and ‘subperiosteal’. The search was limited to articles that had been 
published in English language since the year 2006. The year limitation was 
considered to be in keeping with the publication of the European Position Paper 
(EPSO). 
The primary search revealed 936 papers that matched the search criteria. These 
underwent a title reviewing then a full text reviewing stages prior to identifying a final 
list of 17 articles that were included in the analysis.  
3- Guideline development [24]  
The results of the literature review and of the first cycle of data were employed to 
develop a local guideline for the management of orbital infections. The findings were 
incorporated and analysed collectively to construct a draft for the proposed guideline. 
The resultant draft underwent thereafter “closed-circuit” multidisciplinary scrutiny 
and amendments by specialists in emergency medicine, microbiology, 
ophthalmology, otolaryngology, paediatrics and radiology. Further reviews of the 
guideline were carried out through discussions at multiple departmental meetings. The 
final guideline took the design of a care pathway flowchart fitting an A4 single sided 
sheet and an appendix of a similar size (Figures 1&2). This was approved by the 
Trust’s Medical Director and became integrated within our local guidelines and 
policies. In order to effectively produce an improvement in our practice regarding 
orbital infections, we provided clinicians’ teaching, notified clinicians of the guideline 
via emails, and incorporated the guideline on the Trust’s intranet.  
4- Second cycle 
Following the described intervention, we carried out a second cycle of data reviewing 
over a 2-year period (2014-2015). The two-year sample size represents a convenience 
sampling method that allows sufficient numbers for data comparison. The patients 
search in the second cycle followed the same systematic coding approach, and the 
resulting data was assigned to the same audit performa. Data from the first and second 
cycles was compared in order to measure changes in our practice and quality of care. 
Results (Tables 2-7) 
54 patients during the first audit cycle (2008-2012) and 30 patients during the second cycle 
(2014-2015) were admitted to Plymouth Hospitals NHS Trust (PHNT) with orbital infections. 
Therefore, the incidence of inpatient admissions for orbital infections varied from 10.8 per 
annum in the first cycle to 15 per annum in the second.  Most patients (74% in 1st cycle vs. 
70% in 2nd cycle) were under the age of 17, while 26% of the 1st cycle patients and 30% of 
2nd cycle patients were adults.  The mean age of paediatric patients varied from 5.8 to 6.2 
years between both cycles while the adult mean age was 51years in both cycles.  In both audit 
cycles, most patients (70% in 1st and 87% in 2nd) had a diagnosis of a cellulitis (Chandler’s 
grades I-II). The incidence of subperiosteal and orbital abscesses (Chandler’s grades III-IV) 
varied from 30% and 13% between the first and second cycles. No patients had had any retro-
orbital complications (Chandler’s grades V) during the studied periods. The commonest 
source of patients’ primary referral in both cohorts (63-64%) was from primary care. Other 
patients were mainly (33%) referred from the emergency department and ophthalmology 
clinics.   
In the first studied cohort, the referral of patients to specialist secondary care had been 
delayed in 17% of cases, and all of these delays occurred in primary care. Despite the 
implementation of the changes, this percentage escalated to reach 33% of delayed referrals in 
the second studied cohort. Delays in referrals in the second cycle originated mostly (80%) 
from primary care; however, 20% of delays originated from the emergency department.  
According to the agreed guideline, all patients should receive a multidisciplinary (MTD) 
review promptly on admission (ENT +/- paediatrics +/- ophthalmology). The adherence to 
this decreased slightly from 52% of patients prior to implementing the guideline to 43% 
afterwards.   
Promptness in (within 4 hours of presentation) administering IV antibiotics was measured 
only in the second cycle and our compliance with this was achieved in 87% of patients. 
Similarly, the compliance with the antibiotics choice was measured only in the second cycle 
and was found appropriate in 83% of patients. The use of intravenous Co-Amoxiclav as the 
agreed antibiotic of choice had increased between the audit cycles from 47% to 63% of cases. 
In both data cycles, topical steroids were used in less than 40% of patients and decongestants 
were used in less than 50% of the cases.  
The implementation of the guideline succeeded in reducing the need to contact the on call 
microbiologist from 30% of cases in the first cycle to 13% in the second. Our practice in 
obtaining samples for cultures on admission of patients with orbital infections had improved 
from 48% prior to implementing the guideline to 80% afterwards. Of the obtained samples 
for cultures, 46% in the first cohort and 58% in the second cohort had yielded positive results. 
Staphylococcus and Streptococcus strains constituted the most commonly (59% of positive 
cultures) isolated microbial species in both cycles. One patient in the second cycle had 
Haemophilus Influenzae isolated in their cultures.  The second cycle of data revealed that the 
most successful culture samples in growing bacteria (sensitivity) were the intra-nasal and 
intra-operative samples (66% to 89%). Blood cultures sensitivity was limited to around 20% 
according to our data.   
The use of imaging had successfully decreased after the implementation of the guideline from 
50% to 20% during the patients’ admission period, and from 37% to 10% on the day of 
admission. However, our compliance with the guideline with regards to CT scanning patients 
who have high risk features had worsened from 13% to 77%. Most patients in both cohorts 
were managed conservatively (72% vs. 87%). It is notable that we were more successful after 
the implementation of the guideline in managing high risk patients medically without the 
need for surgery; 73% of high risk patients in the first cycle had surgical drainage as oppose 
to 23% of them in the second cycle.   
The mean of the duration of patients’ in-hospital stay varied from 3.9 days in the first cycle to 
4.4 in the second. Outpatient follow-up planning had increased successfully after applying the 
guideline from 43% in the first cycle to 67% of patients in the second. One death occurred in 
the first cycle in an elderly patient with multiple co-morbidities as a result of a cardiac event 
and multiple organfailure. 
Discussion 
The incidence of admissions to hospitals due to orbital infections in the literature varied from 
4 to 24 patients per annum; in our cohorts of data the incidence was 11 to 15 patients 
annually.  
In our data from both cycles and from our literature review, the most commonly identified 
microbial culprits were staphylococcus and streptococcus species. Other microbes included 
MRSA, anaerobes and mixed other organisms. The sensitivity of cultured sites varied widely 
in literature, but most studies agreed with our findings that samples obtained during surgical 
procedures were the most productive.  
The incidence of abscess formation differed broadly both in the literature (incidence from 1% 
to 83%) and in our audit data arms (13% and 30%). Similarly, imaging using CT scanning 
varied in the reported literature widely from 12% to 92% of patients. In our audit, the use of 
CT had declined from 50% of cases prior to the implementation of the new guideline to 20% 
afterwards.  
Co-Amoxiclav and / or Cefalosporins were found to be the most frequently used antibiotics in 
the literature review. Intravenous Co-Amoxiclav was used in 47% of patients with orbital 
infection in our first audit cycle. After it was considered the antibiotic of choice in the new 
guideline, this percentage became 63% in the second audit cycle.   
We estimated from the literature a mean duration of hospitalisation of 4.24 days for patients 
with orbital infections. The mean of the inpatient stay in our audit ranged from 3.9 days in the 
first cycle to 4.4 days in the second. 
Conclusion  
Orbital infections are relatively commonly seen; they require a hospital admission rate of 
once to twice monthly and an inpatient duration of stay of around four days. Orbital sepsis is 
more frequent in children and can be associated with abscess formation and retro-orbital 
complications. Our tertiary centre audited its practice and initiated a local guidance regarding 
the management of orbital infections. 
Despite the implementation of the new guideline delays are still being seen in referring 
patients with suspected orbital infections for a specialist review. Reducing these delays 
requires the extension of teaching regarding the local guidance to primary care practitioners. 
Moreover, reducing these delays effectively necessitates that we also support secondary care 
doctors’ teaching in order to enhance their awareness of the implemented guideline. Such 
teaching is also required in order to improve our adherence to ensuring the prompt 
multidisciplinary assessment of patients with orbital infections. Nevertheless, we observe 
from our data that the decision making process regarding imaging in high risk orbital 
infections patients should be optimised.   
The guideline implementation was associated with promptness in administering IV antibiotics 
and with compliance with an agreed antimicrobial therapy. Moreover, an increased tendency 
to obtain microbial samples from patients had been observed after the application of the 
guideline. Samples that carry pus (eye, nose, intra-operative) are noted to be more productive 
in identifying a causative organism. Fewer patients with orbital infections were scanned 
following the implementation of the agreed management protocol. However, we succeeded in 
managing high risk patients more conservatively after applying the new guidance. Another 
improvement in our practice between our audit cycles is the success in following orbital 
infections patients up in outpatients more frequently.  
To conclude, there is an observable improvement in the local practice that is associated with 
the implementation of the constructed guideline on the management of orbital infection. 
However, further steps are required in order to develop our care of orbital infections patients. 
Additional actions for future progress can include: 
1- The provision of further clinician teaching in secondary care (continued medical 
education `CME` meetings, Foundation Doctors’ teaching) 
2- Primary care practitioners teaching (GP trainees’ training days, GP continued medical 
education `CME` activities)  
3- The Integration of the guideline into the emergency department electronic folders of 
guidelines, protocols and procedures  
4- An further email based communication to all local doctors regarding the standardised 
management of patients with orbital infections  
5- Liaising with the clinical departmental leads of the departments of emergency 
medicine, ENT, maxillo-facial surgery, ophthalmology, paediatrics, and plastic 
surgery in order to include orbital infections teaching during their departmental 
teaching activities  
6- Repeating a third audit cycle to highlight the long-term compliance with the agreed 
local gold standard  
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Tables & Figures  
Table 1 - Chandler's classification of orbital infections 
Chandler’s Stage Clinical Stage 
I Preseptal cellulitis 
II Orbital cellulitis 
III Subperiosteal abscess 
IV Orbital Abscess 
V Cavernous sinus thrombosis 
 
Table 2 - Audit data - Demographics 
Data measured  1st Cycle 2nd Cycle 
Number of patients 54 30 
Period studied 5 years  2 years 
Age 74% paediatrics   
(mean age 5.8) 
26% adults   
(mean age 51) 
70% paediatrics  
(mean age 6.2) 
30% adults  
(mean age 50.9) 
Chandler’s grade 
 I – II 
 III 
 IV 
 
70% 
20%  
10% 
 
87%  
10%  
3%  
 
Table 3 - Referral, admission and final outcomes 
Data measured  1st Cycle 2nd Cycle 
Referral source   
 Primary care  
 Emergency Dept.  
 Ophthalmology  
 Other  
 
63% 
22% 
11% 
4% 
 
64% 
30% 
3% 
3% 
Delayed referrals   17% delays in referrals  
All delays from primary care 
33% delayed referrals  
80% delays from primary 
care 
20% delays from Emergency 
Dept.  
Prompt multidisciplinary 
team (MDT) on admission  
52%  43%  
Microbiologist involvement 
 Any time  
 On admission day 
 
30% 
7% 
 
13% 
7% 
Length of in-patient stay 
   
3.9 +/- 3.5 days   
(Median 4)  
4.43 +/- 3.5 days  
(Median 3.5)  
Outpatient Follow up 
 Any   
 
43% 
 
67% 
 ENT  37% 20% 
Rhinitis diagnosis on 
follow up    
45% (of ENT follow ups)  (17% of ENT follow ups)  
Death  1 0 
 
Table 4 - Microbiological outcomes 
Data measured  1st Cycle 2nd Cycle 
Cultures   
 None done  
 Negative  
 Positive  
 
52% 
26% (54% of total cultures) 
22% (46% of total cultures) 
 
20% 
33% (42% of total cultures) 
47% (58% of total cultures) 
Cultures results  
Negative 
Positive 
 Staphylococcus 
 Aureus  
 Aureus PVL 
 Epidermis 
 Streptococcus 
 Group A Haem. 
 Intermedius 
 
54%   
 
12% 
8% 
4% 
0 
15% 
4% 
4% 
 
42% 
 
17% 
13% 
0 
4% 
17% 
8.5% 
8.5% 
 Anginosus 
 Pneumoniae 
 Anaerobes   
 H. Influenzae 
 Mixed  
4% 
4% 
4% 
0 
15% 
0 
0 
0 
4% 
21%  
Cultures sites  
 Blood Cx done  
 Nasal Cx done  
 Eye Cx done  
 
30% 
11%  
30% 
 
63% (of whom 21% positive) 
10% (of whom 66% positive)  
60% (of whom 89% positive) 
 
Table 5 - Medical management 
Data measured  1st Cycle 2nd Cycle 
Antibiotics protocol 
compliance  
NA 83%  
Promptness of IV 
antibiotics administration  
Not measured  87%  
Antibiotics choice  IV Co-Amoxiclav 47% 
Oral Co-Amoxiclav 21% 
Co-Amoxiclav had to be 
stopped and changed 9% 
IV Co-Amoxiclav 63%  
Oral Co-Amoxiclav 7% 
Co-Amoxiclav had to be 
stopped and changed 7%  
Combined IVI 9% 
Other than Co-Amoxiclav 
14% (4% allergic)  
Combined ABX 20% 
Ceftriaxone +/- Met 17% 
Topical only 3%  
Other medications  
 IV Steroids   
 Top Steroids   
 Decongestants  
 
None 
37% 
48% 
 
3% 
33% 
43% 
 
Table 6 - Imaging 
Data measured  1st Cycle 2nd Cycle 
Imaging   
 Anytime   
 On admission day 
 
50% 
37% 
 
20% 
10% 
High risk on admission 28% 43% 
High risk – not had CT 13% (OF HIGH RISK) 77% 
 
Table 7 - Surgical management 
Data measured  1st Cycle 2nd Cycle 
Surgery    28% 13% 
High risk - no surgery  27% (of high risk) 77% of high risk  
Revision surgery   13% 7% 
Delayed theatre   None None  
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